CNCR vs. GERM

Last updated Jun 3, 2026

CNCR (Loncar Cancer Immunotherapy ETF) and GERM (Amplify Treatments, Testing and Advancements ETF) are both Health & Biotech Equities funds - CNCR tracks the Loncar Cancer Immunotherapy Index while GERM tracks the Prime Treatments, Testing and Advancements Index. Both are passively managed. CNCR charges 0.79%/yr vs 0.68%/yr for GERM.

Performance

CNCR vs. GERM - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Loncar Cancer Immunotherapy ETF (CNCR) and Amplify Treatments, Testing and Advancements ETF (GERM). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

CNCR

• 1D: 0.00%
• 1M: 0.00%
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

GERM

• 1D: 0.00%
• 1M: 0.00%
• YTD: 0.00%
• 6M: 0.00%
• 1Y: 0.00%
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

CNCR vs. GERM - Yearly Performance Comparison

	2026 (YTD)
CNCR Loncar Cancer Immunotherapy ETF	0.00%
GERM Amplify Treatments, Testing and Advancements ETF	0.00%

CNCR vs. GERM - Sectors Allocation Comparison

Sectors	CNCR	GERM
Healthcare	96.6%	99.3%
Financial Services	3.3%	0.4%
Basic Materials	-	-
Communication Services	-	-
Consumer Cyclical	-	-
Consumer Defensive	-	-
Energy	-	-
Industrials	-	-
Real Estate	-	-
Technology	-	-
Utilities	-	-

Return for Risk

CNCR vs. GERM - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Loncar Cancer Immunotherapy ETF (CNCR) and Amplify Treatments, Testing and Advancements ETF (GERM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

Drawdowns

CNCR vs. GERM - Drawdown Comparison

The maximum CNCR drawdown since its inception was 0.00%, which is greater than GERM's maximum drawdown of 0.00%. Use the drawdown chart below to compare losses from any high point for CNCR and GERM.

Drawdown Indicators

	CNCR	GERM	Difference
Max Drawdown Largest peak-to-trough decline	0.00%	0.00%	0.00%
Max Drawdown (1Y) Largest decline over 1 year	—	0.00%	—
Current Drawdown Current decline from peak	0.00%	0.00%	0.00%
Average Drawdown Average peak-to-trough decline	0.00%	0.00%	0.00%
Ulcer Index Depth and duration of drawdowns from previous peaks	—	0.00%	—

Volatility

Volatility by Period

	CNCR	GERM	Difference
Volatility (1M) Calculated over the trailing 1-month period	—	0.00%	—
Volatility (6M) Calculated over the trailing 6-month period	—	0.00%	—
Volatility (1Y) Calculated over the trailing 1-year period	0.00%	0.00%	0.00%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	0.00%	0.00%	0.00%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	0.00%	0.00%	0.00%

CNCR vs. GERM - Expense Ratio Comparison

CNCR has a 0.79% expense ratio, which is higher than GERM's 0.68% expense ratio.

Dividends

CNCR vs. GERM - Dividend Comparison

Neither CNCR nor GERM has paid dividends to shareholders.

Tickers have no history of dividend payments

Frequently Asked Questions

Which ETF is better, CNCR or GERM?

On fees, GERM is cheaper at 0.68% per year. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF is cheaper, CNCR or GERM?

GERM is cheaper with a 0.68% expense ratio, compared with 0.79% for CNCR.

Which ETF pays a higher dividend yield, CNCR or GERM?

CNCR and GERM have nearly identical dividend yields, around 0.00%.

What is the main difference between CNCR and GERM?

CNCR tracks Loncar Cancer Immunotherapy Index, while GERM tracks Prime Treatments, Testing and Advancements Index. They also come from different issuers: Exchange Traded Concepts and Amplify. Their fees differ too: 0.79% for CNCR and 0.68% for GERM.